Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Learn a New Language

David S. Pisetsky, MD, PhD  |  Issue: June 2011  |  June 13, 2011

In their extraordinary work, the discoverers of TNF (or cachectin) were pursuing fundamental questions, and they did not have rheumatoid arthritis (RA) on their radar screens. In the chaos and jumble of scientific inquiry, however, investigators eventually saw a connection with RA, allowing anti-TNF (after a detour in sepsis) to find a place in clinic where today it is a mainstay in a treatment paradigm that is making remission increasingly possible. That, dear readers, is what scientific advance is all about. Without a long gestation period of heavy duty basic research—protein purification, sequencing, expression cloning, development of functional assays, shooting up mice—the role of TNF in the pathogenesis of inflammatory arthritis likely would have been missed. It was only later when a treasure chest of basic science observations had been filled to the brim that a translational conversation could begin. Most importantly, the individuals pursuing this initial work made progress because they could speak both clinical and basic research languages, making translation possible. Look at the early publications of these investigators. They are replete with top-flight basic science. Without the ability of these pioneers to zig and zag between the clinic and the lab, anti-TNF would likely have been shelved long ago.

Becoming Bilingual

Time was, students in the United States had to take a foreign language to graduate from high school or college. Belief was strong that a truly educated person should know two languages and, by implication, two cultures. (Did you think my adeptness with dropping bon mots and navigating the boîtes on the Left Bank came out of thin air? No, mes amis, it was four years of high school French, disciplined by teachers we called Monsieur and Madame who, sacré bleu, made us conjugate verbs incessantly—Je suis, tu es, il est—working us so hard my derrière turned into rien de tout, and then we had to read Le Malade Imaginaire, La Peste, and Le Père Goriot in French in paperback books whose pages I had to slit apart with a silver letter opener.)

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

To you trainees who want to do translational research, I want you to look deep into your souls and ask yourself a serious question: “Do I know two languages? Do I know science as well as medicine?” If the answer is no, then I say that you should come to the lab for a good long stay. Get a few feet of bench space and a computer with lots of memory. Learn what a mole is, how to make a buffer of pH 7.4, and how to take that flow cytometer for a spin. Make PubMed your friend, and start reading articles. Unlike journal club, no skipping the “Materials and Methods,” because this section often contains the key nuggets for translation.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:Education & TrainingOpinionResearch RheumRheuminationsSpeak Out Rheum Tagged with:Basic researchEducationrheumatologyTrainingtranslational research

Related Articles

    Tips for Selecting Best Job Candidates to Fill Positions, Avoid Turnover

    April 14, 2016

    As much as 80% of employee turnover can be attributed to bad hiring decisions, the Harvard Business Review reported.1 And turnover costs are high—one report estimated them to be 100–300% of the base salary of a replaced employee (with 150% commonly cited).2 Given this, the importance of hiring the right employees can’t be underestimated. So…

    Virtual Recruitment in 2020 and Beyond: Rheumatology Fellowship Program Directors Survey Results

    July 15, 2021

    In response to the COVID-19 pandemic, all rheumatology fellowship interviews conducted in the 2020 fellowship recruitment season were conducted in a virtual, video-based format to reduce the risks associated with travel and face-to-face meetings. In June 2020, the Coalition for Physician Accountability released guidance suggesting all programs commit to online-only interviews and recruitment events, even…

    Make Me A Match

    November 1, 2006

    Rheumatology training programs adopt computerized fellowship selection

    Don’t Get Lost in Translation: Helping rheumatology Patients with Limited English Skills

    January 1, 2010

    Helping rheumatology patients with limited English skills

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences